+------------------------------------------------------------------------------+
BN 12/10 14:11 *TEVA INTERIM CEO SAYS CO. WILL EVALUATE BUYBACK OPPORTUNITIES BN 12/10 14:11 *TEVA INTERIM CEO SAYS CO. SEES DIVIDEND RISING IN 2014 BN 12/10 14:08 *TEVA IS NOT FOR SALE: INTERIM CEO BN 12/10 14:02 *TEVA WOULD NOT IGNORE ANY DEAL OPPORTUNITY: INTERIM CEO BN 12/10 14:02 *TEVA SEEKS ACQUISITIONS TO EXPAND IN EMERGING MKTS BN 12/10 14:01 *TEVA INTERIM CEO SAYS CO. HAS ABILITY TO EXECUTE DEALS BN 12/10 13:57 *TEVA SEES ABT 25% COPAXONE PTS SWITCHING IF GENERIC IN JUNE '14 BN 12/10 13:52 *TEVA SEES ORAL MS DRUGS ABOVE 100K PATS BY END-2014 BN 12/10 13:49 *TEVA INTERIM CEO SEES COPAXONE UNCERTAINTY THROUGH 2015 BN 12/10 13:48 *TEVA INTERIM CEO SAYS WILL KEEP SEEKING COST CUTS THROUGH 2014 BN 12/10 13:44 *TEVA SEES LOW-SINGLE-DIGIT PRICE EROSION IN EUROPE MKT IN '14 BN 12/10 13:34 *TEVA SEES 2014 A `VALLEY' FOR NEW GENERIC DRUGS BN 12/10 13:27 *TEVA SEES 1Q AND 4Q 2014 BETTER THAN 2Q AND 3Q BN 12/10 13:17 *TEVA INTERIM CEO SAYS FINDING PERMANENT CEO IS `HIGH PRIORITY' BN 12/10 13:12 *TEVA EXECUTIVES SPOKE IN CONFERENCE CALL BN 12/10 13:11 *TEVA INTERIM CEO SEES 70% OF COST SAVINGS REALIZED BY END-2015
+------------------------------------------------------------------------------+
*TEVA IS NOT FOR SALE: INTERIM CEO 2013-12-10 14:09:14.245 GMT
--LIBBY SALLABERRY
-0- Dec/10/2013 14:09 GMT